Back to Clinical Trials Overview

Back To Cancer Clinical Trials

Your search for "Breast" returned 7 results:


Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmesis in Patients with Multiple Ipsilateral Breast Cancers
Principal Investigator(s): Elisa Port

A011106- ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III Study
Principal Investigator(s): Dr. Amy Tiersten

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Fulvestrant with or without LY2835219, a CDK4/6 Inhibitor, for Women with Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
Principal Investigator(s): Dr. Amy Tiersten

A Randomized, Double-Blind, Phase 2 Study of Ruxolitinib or Placebo in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-Negative Breast Cancer
Principal Investigator(s): Dr. Amy Tiersten

Safety and Tolerance of Intravenous 4-methyl-4cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients with Malignancies involving the Central Nervous System
Principal Investigator(s): Dr. Philip Friedlander

A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
Principal Investigator(s): Paul Hank Schmidt

Phase I/II Trial of Ruxolitinib in combination with Trastuzumab in Metastatic Her2 positive breast cancer
Principal Investigator(s): Dr. Amy Tiersten